What is the appropriate balance of pharmaceutical costs and benefits in todays economic times?
As healthcare premiums rise, attention increasingly has focused on aggressive management of pharmaceutical costs and coverage. Strategies have included greater levels of employee cost-sharing, formulary restrictions, and tiered benefit structures. Research has shown that such efforts can significantly curb consumer spending. Yet continued innovation and the development and diffusion of new pharmaceuticals and health technologies hold great promise for reducing healthcare costs, enhancing treatment effectiveness, and improving quality and productivity. This stimulating conference brings together cross-sector perspectives in the search for balance among pharmaceuticals value, economic trade-offs, and benefits design. Join us for a stimulating, intersectoral forum geared to: • Health plan executives • Purchasers: Employers, business coalitions, buying groups • Labor and consumer leaders • Health and pharmaceutical benefits managers • Policymakers: Government, academics, economists • Provi
Related Questions
- Are there any personal benefits for leaders from accessing their creativity? Especially in times of economic uncertainty, why bother worrying about personal creativity?
- What else is Progress Energy doing to help customers manage their energy costs during these challenging economic times?
- What is the appropriate balance of pharmaceutical costs and benefits in todays economic times?
